2010
DOI: 10.1007/s00464-010-1236-2
|View full text |Cite
|
Sign up to set email alerts
|

Malignant esophageal dysphagia palliation using insertion of a covered Ultraflex stent without fluoroscopy: a prospective observational study

Abstract: In most cases, SEMSs can be accurately and safely positioned without fluoroscopy for palliative treatment of malignant esophageal dysphagia.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
5

Citation Types

5
14
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
5
1
1

Relationship

0
7

Authors

Journals

citations
Cited by 19 publications
(19 citation statements)
references
References 35 publications
5
14
0
Order By: Relevance
“…Similarly to previous reports for other stents in malignant strictures [9][10][11][12][13][14][15][16][17][18][19][20], stent placement in our cohort was safe and easy in almost all cases (98.8%), with only a minority of patients (18.2%) requiring pre-stent placement dilation. The fully covered WallFlex ® stent provided a good relief of malignant dysphagia, reducing the score from a median of 3 to a median of 1 (P < 0.001) both at 14 days and 4 weeks after stent placement, in line with previous studies.…”
Section: Discussionsupporting
confidence: 88%
See 3 more Smart Citations
“…Similarly to previous reports for other stents in malignant strictures [9][10][11][12][13][14][15][16][17][18][19][20], stent placement in our cohort was safe and easy in almost all cases (98.8%), with only a minority of patients (18.2%) requiring pre-stent placement dilation. The fully covered WallFlex ® stent provided a good relief of malignant dysphagia, reducing the score from a median of 3 to a median of 1 (P < 0.001) both at 14 days and 4 weeks after stent placement, in line with previous studies.…”
Section: Discussionsupporting
confidence: 88%
“…The overall dysphagia recurrence rate with SEMS, for any reason, ranges between 12% and 49% in the literature [10][11][12][13][14][15][16][17][18]23]. Even though our migration rate is slightly higher than a previous experience with the same fully covered WallFlex ® stent, which found a recurrence rate of 15% [7], it falls neatly within the rates of recurrent dysphagia reported in the literature.…”
Section: Discussionsupporting
confidence: 55%
See 2 more Smart Citations
“…1 When esophageal cancers are associated with progressive dysphagia, 60%-70% of them have already lost surgical indications, 2 and stent implantation remains the primary option. [3][4][5][6][7] Esophageal stent implantation can rapidly reestablish the esophageal passage, relieve stricture symptoms, improve the nutritional status and replace esophageal reconstruction surgery, which is risky and traumatic. Therefore, esophageal stent implantation is of high clinical importance.…”
Section: Discussionmentioning
confidence: 99%